# A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation

> **NCT00537459** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 18 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** 16448

## Key facts

- **NCT ID:** NCT00537459
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537459, "A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00537459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*